CASE STUDY 1
Opportunity Assessment and Asset Prioritization
Axiom's Role
1
2
3
Biotech was developing a novel PET imaging agent and needed to understand the overall market potential
Their imaging agent would require a shift in patient management and could be utilized at various stages of disease
Company did not have the resources and internal expertise to conduct market research and develop a model
Axiom developed a model to track patients from early- through late-stage disease enabling understanding of the true market opportunity based on detailed primary and secondary research
We additionally helped support due diligence during acquisition negotiations
Delivered for Client
THE PROJECT TEAM
For more information contact
WHAT MADE THIS SPECIAL
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
TITLE
TITLE
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.